₹ 4.6 Cr
Volume transacted
163.7 K
stocks traded
Last Updated time: 18 Sep 9.00 AM
Marksans Pharma Ltd
NSE: MARKSANS
YEARHIGH
₹ 298.7
Last updated: 18 Sep 24
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
No data available
* All values are consolidated
Last Updated time:
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price | Day Open | Day High | Day Low |
---|
18 Sep 2024 | 281.25 | 296 | 298.7 | 277.2 |
17 Sep 2024 | 296.25 | 294.65 | 297.95 | 284.95 |
16 Sep 2024 | 293.85 | 281.95 | 296.8 | 280 |
13 Sep 2024 | 277.35 | 270.25 | 284.3 | 268.5 |
12 Sep 2024 | 268.1 | 274.25 | 274.95 | 266.85 |
11 Sep 2024 | 272.85 | 265.3 | 276 | 261.1 |
10 Sep 2024 | 263.5 | 262.7 | 273.15 | 259.3 |
09 Sep 2024 | 258.5 | 266.45 | 266.45 | 255.5 |
06 Sep 2024 | 263 | 267.95 | 278.4 | 261.8 |
05 Sep 2024 | 259.3 | 262.55 | 263 | 252.75 |
Date | Price |
---|---|
18 Sep 2024 | 281.25 |
17 Sep 2024 | 296.25 |
16 Sep 2024 | 293.85 |
13 Sep 2024 | 277.35 |
12 Sep 2024 | 268.1 |
11 Sep 2024 | 272.85 |
10 Sep 2024 | 263.5 |
09 Sep 2024 | 258.5 |
06 Sep 2024 | 263 |
05 Sep 2024 | 259.3 |
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Marksans Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Marksans Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Marksans Pharma announces receipt of UKMHRA approval for Fluoxetine capsules
Marksans Pharma'announced that its wholly owned subsidiary Relonchem has received Marketin...
Read more
21 Aug 202420:00
Marksans Pharma's Verna unit successfully completes USFDA inspection
Marksans Pharma announced that he USFDA has issued an Establishment Inspection Report (EIR...
Read more
20 Aug 202414:37
Marksans Pharma to convene AGM
Marksans Pharma announced that the Annual General Meeting (AGM) of the company will be hel...
Read more
20 Aug 202410:46
Marksans Pharma gets EIR from USFDA for Goa facility
The inspection has been classified as voluntary action indicated (VAI) and has been closed...
Read more
20 Aug 202414:48
Marksans Pharma surges after Q1 PAT rises 29% YoY to Rs 89 cr
Revenue from operations jumped 18.12% YoY to Rs 590.62 crore in first quarter of FY25, dri...
Read more
14 Aug 202412:04
Marksans announces receipt of marketing authorization for Levonorgestrel 1.5 mg Tablets
Marksans Pharma announced that its wholly owned subsidiary Relonchem has received Marketin...
Read more
02 Aug 202416:12
FAQs for 52 Week High of Marksans Pharma Ltd
What is the significance of Marksans Pharma Ltd reaching its 52-week high?
Why do investors monitor Marksans Pharma Ltd 52-week high?
Is Marksans Pharma Ltd a good buy when it hits its 52-week high?
What should I consider before investing in Marksans Pharma Ltd at its 52-week high?
Can Marksans Pharma Ltd stock price continue to rise after reaching its 52-week high?
Unlimited trading at just
Rs. 199*